Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China flag China · Delayed Price · Currency is CNY
14.70
-0.11 (-0.74%)
May 20, 2026, 1:25 PM CST

Cisen Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,7057,8426,2216,6015,6685,978
Market Cap Growth
6.85%26.05%-5.76%16.46%-5.19%-4.03%
Enterprise Value
3,5854,5813,7824,0823,3643,917
Last Close Price
14.8117.3213.4013.6511.4811.87
PE Ratio
16.4418.6112.2212.6616.2017.89
Forward PE
-46.9546.9546.9546.9546.95
PS Ratio
1.992.281.561.481.391.58
PB Ratio
1.051.261.041.151.061.18
P/TBV Ratio
1.091.311.081.201.111.23
P/FCF Ratio
12.4619.5313.2615.2325.4032.74
P/OCF Ratio
11.1516.8110.9014.6321.9425.59
EV/Sales Ratio
1.061.330.950.920.831.03
EV/EBITDA Ratio
8.049.825.685.226.479.07
EV/EBIT Ratio
14.0616.918.517.4111.5518.28
EV/FCF Ratio
6.6611.418.069.4115.0821.45
Debt / Equity Ratio
0.010.010.020.030.030.03
Debt / EBITDA Ratio
0.090.090.170.220.300.33
Debt / FCF Ratio
0.080.110.250.390.710.79
Net Debt / Equity Ratio
-0.50-0.54-0.45-0.45-0.49-0.45
Net Debt / EBITDA Ratio
-7.12-7.21-4.03-3.33-5.05-5.28
Net Debt / FCF Ratio
-5.87-8.37-5.71-6.01-11.76-12.49
Asset Turnover
0.440.460.540.630.620.60
Inventory Turnover
2.482.422.392.973.112.96
Quick Ratio
3.593.632.723.023.172.86
Current Ratio
4.654.263.333.633.703.40
Return on Equity (ROE)
6.61%6.97%8.76%9.45%6.77%6.78%
Return on Assets (ROA)
2.09%2.23%3.73%4.87%2.76%2.14%
Return on Invested Capital (ROIC)
7.23%7.52%12.29%16.48%10.17%7.92%
Return on Capital Employed (ROCE)
3.90%4.30%7.30%9.20%5.30%4.20%
Earnings Yield
6.09%5.37%8.18%7.90%6.17%5.59%
FCF Yield
8.03%5.12%7.54%6.57%3.94%3.05%
Dividend Yield
2.75%2.01%3.28%3.19%2.92%2.53%
Payout Ratio
44.76%43.42%59.85%29.95%39.87%36.13%
Buyback Yield / Dilution
-0.02%0.31%-0.23%0.25%-0.65%0.18%
Total Shareholder Return
2.73%2.32%3.05%3.45%2.27%2.71%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.